Analyst consensus rating
Phio Pharmaceuticals Analyst Rating: Strong Buy
Direct answer
Phio Pharmaceuticals's consensus rating is Strong Buy.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $14.00.
Forecast evidence checked October 5, 2026.
Get free Phio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.99
- Average price target
- $14.00
- High price target
- $14.00
- Low price target
- $14.00
- Low target gap
- +1,321.2%
- Target upside
- +1,321.2%
- High target gap
- +1,321.2%
- Target range width
- 0%
- Consensus rating
- Strong Buy
- Analysts
- 1
- Evidence date
- October 5, 2026
- Valid through
- October 12, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Phio Pharmaceuticals?
Phio Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $14.00.
How far are Phio Pharmaceuticals's low and high targets from the recorded price?
The low target implies +1,321.2%, while the high target implies +1,321.2%.
How many analysts are included in Phio Pharmaceuticals's consensus?
The verified consensus includes 1 analysts.
How is Phio Pharmaceuticals's target upside or downside calculated?
The average target of $14.00 is divided by the recorded price of $0.99, then one is subtracted to produce +1,321.2%. This does not guarantee a future return.
When was Phio Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-10-05. The dataset is valid through 2026-10-12.